Quantbot Technologies LP raised its holdings in shares of Vital Farms, Inc. (NASDAQ:VITL - Free Report) by 635.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 55,114 shares of the company's stock after acquiring an additional 47,623 shares during the quarter. Quantbot Technologies LP owned approximately 0.13% of Vital Farms worth $1,933,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds have also recently modified their holdings of the company. Van ECK Associates Corp lifted its position in Vital Farms by 8.6% during the second quarter. Van ECK Associates Corp now owns 4,095 shares of the company's stock valued at $192,000 after purchasing an additional 323 shares in the last quarter. Robeco Institutional Asset Management B.V. grew its stake in shares of Vital Farms by 4.4% during the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 7,857 shares of the company's stock valued at $276,000 after acquiring an additional 329 shares during the period. Lifestyle Asset Management Inc. increased its holdings in Vital Farms by 6.5% in the 3rd quarter. Lifestyle Asset Management Inc. now owns 9,846 shares of the company's stock worth $345,000 after acquiring an additional 598 shares in the last quarter. CWM LLC raised its stake in Vital Farms by 162.9% during the 2nd quarter. CWM LLC now owns 1,057 shares of the company's stock worth $49,000 after acquiring an additional 655 shares during the period. Finally, nVerses Capital LLC lifted its holdings in Vital Farms by 66.7% during the second quarter. nVerses Capital LLC now owns 2,000 shares of the company's stock valued at $94,000 after purchasing an additional 800 shares in the last quarter. Institutional investors own 98.59% of the company's stock.
Vital Farms Price Performance
Shares of VITL traded up $0.86 during midday trading on Friday, hitting $33.20. 1,236,853 shares of the company traded hands, compared to its average volume of 816,000. The stock has a market cap of $1.45 billion, a price-to-earnings ratio of 29.28 and a beta of 0.97. The firm has a 50 day moving average of $34.76 and a 200-day moving average of $36.70. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.81 and a current ratio of 3.24. Vital Farms, Inc. has a 52 week low of $12.82 and a 52 week high of $48.41.
Vital Farms (NASDAQ:VITL - Get Free Report) last announced its quarterly earnings results on Thursday, November 7th. The company reported $0.16 EPS for the quarter, beating analysts' consensus estimates of $0.14 by $0.02. Vital Farms had a return on equity of 22.29% and a net margin of 8.68%. The company had revenue of $145.00 million during the quarter, compared to analyst estimates of $145.27 million. During the same period in the prior year, the company earned $0.10 earnings per share. The firm's revenue was up 31.3% on a year-over-year basis. On average, analysts forecast that Vital Farms, Inc. will post 1.11 EPS for the current fiscal year.
Insider Activity
In related news, CEO Russell Diez-Canseco sold 44,653 shares of the stock in a transaction dated Monday, October 14th. The shares were sold at an average price of $40.07, for a total value of $1,789,245.71. Following the completion of the transaction, the chief executive officer now owns 537,349 shares of the company's stock, valued at approximately $21,531,574.43. This trade represents a 7.67 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Matthew Ohayer sold 24,000 shares of Vital Farms stock in a transaction dated Monday, October 21st. The stock was sold at an average price of $39.09, for a total value of $938,160.00. Following the completion of the transaction, the insider now owns 7,194,777 shares of the company's stock, valued at approximately $281,243,832.93. This represents a 0.33 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 27.60% of the company's stock.
Wall Street Analyst Weigh In
VITL has been the topic of several recent analyst reports. Stifel Nicolaus decreased their price objective on shares of Vital Farms from $42.00 to $34.00 and set a "hold" rating on the stock in a research report on Friday, August 9th. DA Davidson raised their price target on Vital Farms from $44.00 to $48.00 and gave the company a "buy" rating in a report on Thursday, October 10th. Jefferies Financial Group lowered their price objective on Vital Farms from $45.00 to $41.00 and set a "buy" rating on the stock in a research report on Monday, November 11th. Finally, TD Cowen cut their target price on Vital Farms from $46.00 to $41.00 and set a "buy" rating for the company in a research report on Friday, November 8th. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, Vital Farms presently has a consensus rating of "Moderate Buy" and an average price target of $39.20.
Get Our Latest Research Report on VITL
Vital Farms Profile
(
Free Report)
Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.
Featured Stories
Before you consider Vital Farms, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vital Farms wasn't on the list.
While Vital Farms currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.